Cutler Group LP Ginkgo Bioworks Holdings, Inc. Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Jul 18, 2023	SELL	$1.14 - $1.95 $2,849 - $4,875	-2,500 Reduced 40.98%	3,600 $0
Q1 2023 May 01, 2023	SELL	$1.2 - $2.19 $77,280 - $141,036	-64,400 Reduced 91.35%	6,100 $0
Q4 2022 Feb 07, 2023	SELL	$1.63 - $3.52 $69,112 - $149,248	-42,400 Reduced 37.56%	70,500 $4,000
Q3 2022 Oct 25, 2022	BUY	$0.73 - $3.74 $64,751 - $331,738	88,700 Added 366.53%	112,900 $20,000
Q2 2022 Aug 04, 2022	SELL	$2.2 - $4.2 $40,480 - $77,280	-18,400 Reduced 43.19%	24,200 $2,000
Q1 2022 Apr 14, 2022	SELL	$2.83 - $8.69 $183,101 - $562,243	-64,700 Reduced 60.3%	42,600 $9,000
Q4 2021 Jan 18, 2022	BUY	$8.31 - $14.92 $261,765 - $469,980	31,500 Added 41.56%	107,300 $59,000
Q3 2021 Oct 26, 2021	BUY	$9.15 - $13.28 $693,570 - $1.01 Million	75,800 New	75,800 $61,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.6B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.